Applied cancer immunogenomics: leveraging neoantigen discovery in glioblastoma

TM Johanns, GP Dunn - The Cancer Journal, 2017 - journals.lww.com
Glioblastoma (GBM) remains a significant cause of cancer-related mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …

Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.

TM Johanns, GP Dunn - Cancer Journal (Sudbury, Mass.), 2017 - europepmc.org
Glioblastoma (GBM) remains a significant cause of cancer-related mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …

Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma

TM Johanns, GP Dunn - Cancer journal (Sudbury, Mass.), 2017 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) remains a significant cause of cancer-related mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …

Applied cancer immunogenomics leveraging neoantigen discovery in glioblastoma

TM Johanns, GP Dunn - Cancer Journal (United States), 2017 - profiles.wustl.edu
Glioblastoma (GBM) remains a significant cause of cancerrelated mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …

[HTML][HTML] Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma

TM Johanns, GP Dunn - Cancer journal (Sudbury, Mass.), 2017 - ncbi.nlm.nih.gov
Glioblastoma (GBM) remains a significant cause of cancer-related mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …

Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.

TM Johanns, GP Dunn - Cancer Journal (Sudbury, Mass.), 2017 - europepmc.org
Glioblastoma (GBM) remains a significant cause of cancer-related mortality in pediatric and
adult patients with limited treatment options. Immunotherapy represents a promising new …